Retroviral protease inhibiting compounds

Details Retroviral protease inhibiting compounds Retroviral protease inhibiting compounds

1997-03-20

1999-03-23

Travers, Russell

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514365, A61K 31425, A61K 31235

Patent

active

058860363

ABSTRACT:
A retroviral protease inhibiting compound of the formula: ##STR1## is disclosed.

REFERENCES:
patent: 4172094 (1979-10-01), Dybas et al.
patent: 4618619 (1986-10-01), Regel et al.
patent: 4644055 (1987-02-01), Kettner et al.
patent: 4652552 (1987-03-01), Kettner et al.
patent: 5142056 (1992-08-01), Kempf et al.
patent: 5354866 (1994-10-01), Kempf et al.
patent: 5541206 (1996-07-01), Kempf et al.
patent: 5674882 (1997-10-01), Kempf et al.

Affiliated with

Also associated with

Rating

Retroviral protease inhibiting compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retroviral protease inhibiting compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retroviral protease inhibiting compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2125827